Literature DB >> 25194056

Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.

Surya Prakash Pandey1, Himanshu Singh Chandel1, Sunit Srivastava1, Sathishkumar Selvaraj1, Mukesh Kumar Jha1, Divanshu Shukla1, Thomas Ebensen2, Carlos A Guzman2, Bhaskar Saha3.   

Abstract

TLRs recognize pathogen-expressed Ags and elicit host-protective immune response. Although TLR2 forms heterodimers with TLR1 or TLR6, recognizing different ligands, differences in the functions of these heterodimers remain unknown. In this study, we report that in Leishmania major-infected macrophages, the expression of TLR1 and TLR2, but not TLR6, increased; TLR2-TLR2 association increased, but TLR2-TLR6 association diminished. Lentivirus-expressed TLR1-short hairpin RNA (shRNA) or TLR2-shRNA administration reduced, but TLR6-shRNA increased L. major infection in BALB/c mice. Corroboratively, Pam3CSK4 (TLR1-TLR2 ligand) and peptidoglycan (TLR2 ligand) increased L. major infection but reduced TLR9 expression, whereas pegylated bisacycloxypropylcysteine (BPPcysMPEG; TLR2-TLR6 ligand) reduced L. major number in L. major-infected macrophages, accompanied by increased TLR9 expression, higher IL-12 production, and inducible NO synthase expression. Whereas MyD88, Toll/IL-1R adaptor protein, and TNFR-α-associated factor 6 recruitments to TLR2 were not different in Pam3CSK4-, peptidoglycan-, or BPPcysMPEG-treated macrophages, only BPPcysMPEG enhanced p38MAPK and activating transcription factor 2 activation. BPPcysMPEG conferred antileishmanial functions to L. major-infected BALB/c-derived T cells in a macrophage-T cell coculture and in BALB/c mice; the protection was TLR6 dependent and IL-12 dependent, and it was accompanied by reduced regulatory T cell number. BPPcysMPEG administration during the priming with fixed L. major protected BALB/c mice against challenge L. major infection; the protection was accompanied by low IL-4 and IL-10, but high IFN-γ productions and reduced regulatory T cells. Thus, BPPcysMPEG, a novel diacylated lipopeptide ligand for TLR2-TLR6 heterodimer, induces IL-12-dependent, inducible NO synthase-dependent, T-reg-sensitive antileishmanial protection. The data reveal a novel dimerization partner-dependent duality in TLR2 function.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25194056     DOI: 10.4049/jimmunol.1400672

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Peptidoglycan-treated tumor antigen-pulsed dendritic cells impart complete resistance against tumor rechallenge.

Authors:  A Patidar; S Selvaraj; P Chauhan; C A Guzman; T Ebensen; A Sarkar; D Chattopadhyay; B Saha
Journal:  Clin Exp Immunol       Date:  2020-06-26       Impact factor: 4.330

Review 2.  Redundant and regulatory roles for Toll-like receptors in Leishmania infection.

Authors:  P Chauhan; D Shukla; D Chattopadhyay; B Saha
Journal:  Clin Exp Immunol       Date:  2017-08-07       Impact factor: 4.330

Review 3.  Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.

Authors:  Mariya Farooq; Abdul Waheed Khan; Bilal Ahmad; Moon Suk Kim; Sangdun Choi
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

4.  TLR2 dimer-specific ligands selectively activate protein kinase C isoforms in Leishmania infection.

Authors:  Arkajyoti Mukherjee; Sayoni Roy; Ashok Patidar; Neelam Bodhale; Jagneswar Dandapat; Bhaskar Saha; Arup Sarkar
Journal:  Immunology       Date:  2021-06-07       Impact factor: 7.215

5.  Interdependencies between Toll-like receptors in Leishmania infection.

Authors:  Divanshu Shukla; Ashok Patidar; Uddipan Sarma; Prashant Chauhan; Surya Prakash Pandey; Himanshu Singh Chandel; Neelam Bodhale; Soumya Kanti Ghosh; Carlos Alberto Guzman; Thomas Ebensen; Ricardo Silvestre; Arup Sarkar; Bhaskar Saha; Surajit Bhattacharjee
Journal:  Immunology       Date:  2021-05-26       Impact factor: 7.215

6.  Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice.

Authors:  Lu Huang; Meleana Hinchman; Susana Mendez
Journal:  PLoS Negl Trop Dis       Date:  2015-03-04

7.  The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models.

Authors:  Alice Halliday; Joseph D Turner; Ana Guimarães; Paul A Bates; Mark J Taylor
Journal:  Parasit Vectors       Date:  2016-02-20       Impact factor: 3.876

8.  Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver.

Authors:  Julia Volckmar; Marcus Gereke; Thomas Ebensen; Peggy Riese; Lars Philipsen; Stefan Lienenklaus; Dirk Wohlleber; Robert Klopfleisch; Sabine Stegemann-Koniszewski; Andreas J Müller; Achim D Gruber; Percy Knolle; Carlos A Guzman; Dunja Bruder
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

Review 9.  Pluripotency and Growth Factors in Early Embryonic Development of Mammals: A Comparative Approach.

Authors:  Lola Llobat
Journal:  Vet Sci       Date:  2021-05-04

10.  Toll-Like Receptor 2 Targeted Rectification of Impaired CD8⁺ T Cell Functions in Experimental Leishmania donovani Infection Reinstates Host Protection.

Authors:  Syamdas Bandyopadhyay; Santanu Kar Mahapatra; Bidisha Paul Chowdhury; Mukesh Kumar Jha; Shibali Das; Kuntal Halder; Suchandra Bhattacharyya Majumdar; Bhaskar Saha; Subrata Majumdar
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.